Department of Neurosurgery, Back and Spine Center, Ochsner Neuroscience Institute, Ochsner Health System, and Tulane University Medical Center, New Orleans, Louisiana.
Laboratory of Neural Injury and Regeneration, Institute of Translational Research, Ochsner Medical Center, New Orleans, Louisiana.
Neurosurgery. 2018 Jun 1;82(6):894-902. doi: 10.1093/neuros/nyx362.
The lack of nerve regeneration and functional recovery occurs frequently when injuries involve large nerve trunks because insufficient mature axons reach their targets in the distal stump and because of the loss of neurotrophic support, primarily from Schwann cells (SCs).
To investigate whether a single application of transforming growth factor-beta (TGF-β) plus forskolin or forskolin alone can promote and support axonal regeneration through the distal nerve stump.
Using a delayed repair rat model of nerve injury, we transected the tibial nerve. After 8 wk, end-to-end repair was done and the repair site was treated with saline, forskolin, or TGF- β plus forskolin. After 6 wk, nerve sections consisting of the proximal stump, distal to the site of repair, and the most distal part of the nerve stump were removed for nerve histology, axon counts, and immunohistochemistry for activated SCs (S100), macrophages (CD68), cell proliferation (Ki67), p75NGFR, and apoptosis (activated caspase-3).
TGF-β plus forskolin significantly increased the numbers of axons regenerated distal to the repair site and the most distal nerve sections. Both treatments significantly increased the numbers of axons regenerated in the most distal nerve sections compared to saline treated. Both treatments exhibited extended expression of regeneration-associated marker proteins.
TGF-β plus forskolin treatment of chronically injured nerve improved axonal regeneration and increased expression of regeneration-associated proteins beyond the repair site. This suggests that a single application at the site of repair has mitogenic effects that extended distally and may potentially overcome the decrease in regenerated axon over long distance.
当损伤涉及大的神经干时,经常会出现神经再生和功能恢复不足的情况,因为到达远端残端的成熟轴突数量不足,并且由于神经营养支持的丧失,主要来自施万细胞(SCs)。
研究转化生长因子-β(TGF-β)加福司可林或福司可林单独应用是否可以促进和支持通过远端神经残端的轴突再生。
使用大鼠神经损伤延迟修复模型,横断胫骨神经。8 周后,进行端端修复,并在修复部位用生理盐水、福司可林或 TGF-β加福司可林处理。6 周后,取出包括近端残端、修复部位远端和神经残端最远端的神经切片进行神经组织学、轴突计数以及激活的施万细胞(S100)、巨噬细胞(CD68)、细胞增殖(Ki67)、p75NGFR 和细胞凋亡(活化 caspase-3)的免疫组化染色。
TGF-β加福司可林显著增加了修复部位远端和最远端神经节段再生的轴突数量。与生理盐水处理相比,两种处理都显著增加了最远端神经节段再生的轴突数量。两种处理均表现出与再生相关的标记蛋白的表达延长。
慢性损伤神经的 TGF-β加福司可林治疗改善了轴突再生,并增加了修复部位以外的与再生相关蛋白的表达。这表明在修复部位单次应用具有有丝分裂作用,可以向远端延伸,并可能潜在地克服长距离再生轴突数量的减少。